National Expansion AOM Infusion holds a nationwide pharmacy license across all 50 states and is expanding therapy solutions and investing in innovative platforms, enabling life‑cycle infusion partnerships with national health systems seeking a single, standardized infusion provider for IVIG and other specialty therapies.

Strategic Partnerships Recent and ongoing Kedrion Biopharma collaborations position AOM Infusion as a preferred national IVIG partner within Kedrion's distribution network, creating opportunities to secure additional contracts and cross-sell infusion therapies to Kedrion's network of clinics and hospitals.

Investment Backing Capital backing from Revelstoke Capital Partners signals growth and scale potential, supporting faster deployment of expanded service lines and digital platforms to attract large multi-site networks and enterprise accounts.

Geographic Footprint Expansion, including a New York presence, demonstrates reach into high‑need urban markets where hospitals and health systems increasingly demand reliable infusion services for IVIG and chronic therapies.

Tech Enabled Care Adoption of a tech‑forward stack including AI chat, automated communications, and secure workflows indicates an ability to improve patient engagement, scheduling, and care coordination—addressing health system goals for efficiency and patient experience in infusion centers.